Point72 Hong Kong LTD Innoviva, Inc. Transaction History

Point72 Hong Kong LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$11.61 - $15.22 $235,172 - $308,296	20,256 Added 21322.11%	20,351 $236,000
Q2 2022 Aug 15, 2022	SELL	$14.32 - $19.88 $55,089 - $76,478	-3,847 Reduced 97.59%	95 $1,000
Q1 2022 May 16, 2022	BUY	$15.39 - $20.25 $60,667 - $79,825	3,942 New	3,942 $76,000
Q4 2019 Feb 14, 2020	SELL	$10.28 - $14.38 $2,220 - $3,106	-216 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$10.05 - $14.55 $1,115 - $1,615	111 Added 105.71%	216 $2,000
Q2 2019 Aug 14, 2019	BUY	$13.1 - $14.95 $445 - $508	34 Added 47.89%	105 $2,000
Q1 2019 May 15, 2019	BUY	$13.69 - $20.06 $971 - $1,424	71 New	71 $1,000

228

79.1M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.32B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.